Skip to main content
. 2019 Sep 27;33(6):2559–2571. doi: 10.1111/jvim.15572

Table 2.

Main echocardiographic diagnosis at baseline

Echocardiographic diagnosis Benazepril (n = 77) Placebo (n = 74) P value
Hypertrophic cardiomyopathy 28 33 .32
Hypertrophic obstructive cardiomyopathy 12 19 .16
Restrictive cardiomyopathy 10 4 .16
Unclassified cardiomyopathy 8 6 .78
Dilated cardiomyopathy 4 7 .36
Mitral valve dysplasia 4 1 .37
Aortic stenosisa 3 0 .25
Ventricular septal defect plus mitral or tricuspid valve dysplasia 3 0 .25
Ventricular septal defect 2 2 1.0
Atrial septal defect 1 0 1.0
Mitral valve regurgitation 1 0 1.0
Tricuspid valve insufficiency 0 1 .49
Not recorded 1 1 1.0

Notes: Data are number of cases in each group at baseline. P values were calculated with Fisher's exact test.

a

One case of hypertrophic cardiomyopathy in the benazepril group had in addition aortic stenosis.